Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...

Growth is being driven by the increased adoption of IoT and AI in industrial environments, which enhance productivity, efficiency, and real-time decision-making. However, high initial capital ...

The global US Healthcare Analytics Market, valued at US$15.84 billion in 2024, is forecasted to grow at a robust CAGR of 24.5 ...

The directive follows the Trump administration’s broader agenda to gut efforts to document and address climate change.

The entry into force of the Regulation on the European Health Data Space (EHDS) is seen by many as a milestone for healthcare ...

Wellgistics Health (WGRX) completed a third-party audit and achieved SOC 2 Type 1 compliance. This milestone validates that Wellgistics Health ...

The Senate confirmed two of President Donald Trump’s health nominees Tuesday evening, largely along party lines, in a win for ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Personnel Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman ...

Artificial Intelligence (AI) has leapt from sci-fi to real-world with incredible speed. But sorting through AI's noisy, hype-filled landscape to find valuable use cases requires both a discerning ...

The winners in the 2025 European Private Label Awards have been announced, recognising outstanding achievements in store ...